How Advanced Are New Modalities? Where Are the Fields Opening Up?

• Summarizing the field’s progress across disease areas, including the state of play of different modalities. How do you innovate beyond existing MoAs?
• Considerations for the right modality: working with more established technologies versus promising new pharmacokinetics

Speakers:

Jackie von Salm

Co-Founder & Chief Scientific Officer

Psilera

Michael Bowen

Co-Founder & Chief Scientific Officer

Kinoxis Therapeutics

Arun Swaminathan

Chief Executive Officer

Coya Therapeutics

Miquel Vila-Perello

Founder & Chief Executive Officer

Splice Bio

Xiyun (Charles) Chai

Senior Vice President of Biology

Argo Biopharma